Introduction
Tuberous sclerosis complex (TSC) is an inherited syndrome in which aected individuals are at increased risk for developing benign tumors (Roach et al., 1998) . Common benign tumors in this condition include hamartomas, rhabdomyomas, angio®bromas, ®bromas, and subependymal nodules. Rarely, more malignant tumors, such as renal cell carcinoma, may develop. Central nervous system (CNS) manifestations include mental retardation, autism, and seizures. In the brain, subependymal nodules are frequently found, and may evolve into subependymal giant cell astrocytomas (SEGAs). There is also evidence of abnormal neuronal migration and development, such as focal cortical dysplasias and the characteristic`tubers' containing increased numbers of astrocytes (Gomez et al., 1999) .
Linkage analysis of TSC resulted in the identi®cation of two distinct genetic loci on chromosomes 9 and 16 (Povey et al., 1994) . The corresponding genes, TSC1 and TSC2, respectively, are mutated in these families, and loss of heterozygosity (LOH) for the respective genetic regions has been demonstrated in lesions from patients with both familial and sporadic TSC (Henske et al., 1996; Green et al., 1994; van Slegtenhorst et al., 1999) . Thus, TSC1 and TSC2 follow the classic retinoblastoma tumor suppressor gene model and appear to function as negative growth regulators. The TSC1 gene product, hamartin, is a 130 kDa hydrophobic protein that lacks signi®cant sequence similarity to any known mammalian protein (van Slegtenhorst et al., 1997) . Hamartin contains a predicted coiled-coil domain which mediates its interaction with the TSC2 gene product, tuberin (van Slegtenhorst et al., 1998) . Recent evidence suggests that hamartin expression stabilizes tuberin expression in the tuberin-hamartin complex . Overexpression of hamartin results in growth suppression in vitro and increased amounts of the cell cycle regulator, p27-Kip1 (Miloloza et al., 2000) . In addition, hamartin overexpression is associated with changes in the actin cytoskeleton and RhoA activation that, in part, are related to its ability to associate with actin binding proteins of the ERM family (Lamb et al., 2000) .
The TSC2 gene product, tuberin, is a 180 ± 200 kDa protein that contains a coiled-coil domain believed to mediate its interaction with hamartin and a carboxyl terminal GTPase activating protein (GAP) homology domain (The European Chromosome 16 Tuberous Sclerosis Consortium, 1993; Wienecke et al., 1995) . As demonstrated for hamartin, tuberin overexpression results in reduced cell proliferation in vitro (Jin et al., 1996) as well as stabilization of p27-Kip1 (Soucek et al., 1998) and hamartin . The minimal domain required for tuberin growth suppression resides in the carboxyl terminus of the protein that contains the GAP domain. Based on its in vitro GAP activity towards Rap1, it has been hypothesized that tuberin might function as a tumor suppressor by inhibiting Rap1 activity. In some cell lines, activation of Rap1 is associated with transformation and tumor formation in vivo (Altschuler and Ribeiro-Neto, 1998) . Moreover, TSC2 missense mutations have been reported in the GAP domain that would be predicted to abrogate GAP activity (Maheshwar et al., 1997) . Consistent with its proposed tumor suppressor function, tuberin expression was reduced in one third of sporadic astrocytomas Gutmann et al., 2000) .
In addition to Rap1GAP activity, tuberin has also been proposed to regulate¯uid phase endocytosis. By yeast two-hybrid interaction cloning, tuberin was shown to interact with rabaptin, a Rab5 binding adaptor molecule (Xiao et al., 1997) . Moreover, rat embryonic ®broblasts lacking tuberin expression were found to have an increased rate of¯uid phase endocytosis. In addition, recent studies have suggested that tuberin might be important for membrane targeting of proteins, such as the polycystic kidney disease (PKD1) gene product, polycystin (Kleymenova et al., 2001) .
The major central nervous system abnormalities seen in individuals with TSC may result from defects in astrocyte function that re¯ect reduced or absent expression of the TSC gene products, hamartin and tuberin. Several lines of evidence implicate the Tsc gene products in astrocyte growth regulation. First, individuals aected with TSC develop astrocyte tumors (SEGAs). Second, reduced or absent TSC2 expression is observed in 30% of high grade sporadic astrocytomas Gutmann et al., 1997) . Third, Tsc gene expression is modulated by cell contact growth arrest in astrocytes (Gutmann et al., 2000) .
Two recent observations have suggested that heterozygosity for TSC may be sucient to result in cell growth abnormalities. First, mutational analysis studies have suggested that some of the brain pathology in TSC may result from TSC gene heterozygosity and not bi-allelic inactivation (Henske et al., 1996; Wolf et al., 1997; Niida et al., 2001; Parry et al., 2000) . Second, the Tsc1 or Tsc2 gene products in Drosophila antagonize insulin receptor signaling Potter et al., 2001; Gao and Pan, 2001) . Heterozygosity for, as opposed to loss of, Tsc1 or Tsc2 is sucient to rescue the lethality of loss of function Drosophila insulin receptor mutants (Gao and Pan, 2001) . Based on these observations, we hypothesize that reduced Tsc gene expression may provide a growth advantage to astrocytes relevant to the pathogenesis of the benign CNS abnormalities seen in individuals with TSC. To determine the consequences of Tsc gene heterozygosity on astrocyte function, we analysed the eects of reduced tuberin and hamartin expression on astrocyte growth in vitro and in vivo. In this report, we demonstrate that Tsc heterozygosity confers a non cell autonomous astrocyte growth advantage that may re¯ect the ability of tuberin to regulate p27-Kip1 stability.
Results
Heterozygosity for the Tsc gene products resulted in increased astrocyte numbers in vivo To determine if reduced hamartin or tuberin expression in Tsc1+/7 or Tsc2+/7 mice, respectively, had an eect on the number of brain astrocytes in vivo, the number of GFAP-immunoreactive cells were counted in a well-de®ned area of the brain (hippocampus CA1 region) using methods previously employed in our laboratory to demonstrate a cell autonomous growth advantage for astrocytes from mice heterozygous for a mutation in the neuro®bromatosis 1 (Nf1) tumor suppressor gene (Gutmann et al., 1999) . Increased numbers of GFAP-immunoreactive astrocytes were observed in Tsc1+/7 (Figure 1 ) as well as Tsc2+/7 (Figure 2 ) mice compared to wild type littermates. We observed a *50% increase in astrocyte number in both the Tsc1 and Tsc2 heterozygote mice. The magnitude of this increase was indistinguishable between Tsc1+/7 and Tsc2+/7 mice. No morphological abnormalities were seen in either the Tsc1+/7 or Tsc2+/7 mouse brains and the CA1 regions counted were identical in terms of total cross-sectional area.
To determine whether the increase in GFAP immunoreactivity re¯ected astrogliosis, we homogenized brains from Tsc2+/7 and wild type littermate mice and determined the expression of three proteins associated with reactive astrogliosis, GFAP, vimentin and Apolipoprotein E (ApoE), by Western blotting. Vimentin is an intermediate ®lament protein expressed in immature and reactive astrocytes (Eddleston and Mucke, 1993; Lendahl et al., 1990) , while ApoE upregulation correlates with astrogliosis (Mouchel et al., 1995) . No increased expression of vimentin, ApoE, or GFAP was observed in brains from Tsc2+/7 mice compared with wild type mice (Figure 3) , suggesting that the increase in the number of GFAP-immunoreactive astrocytes was not a result of reactive astrogliosis (Rizvi et al., 1999) , but rather increased astrocyte number.
To determine whether heterozygosity for Tsc2 could cooperate with Tsc1+/7 to confer a synergistic growth advantage for astrocytes in vivo, we analysed the number of astrocytes in the hippocampi from Tsc1 and Tsc2 double heterozygote mice (Tsc1+/7; Tsc2+/7). We found a twofold increase in the number of GFAP-immunoreactive astrocytes in Tsc1+/7;Tsc2+/7 compound heterozygous mice compared to the 50% increase observed in either Tsc1+/7 or Tsc2+/7 single heterozygous animals alone (Figure 4a ). These ®ndings suggest that Tsc1 and Tsc2 act cooperatively to negatively regulate astrocyte growth.
Based on previous work on the Nf1 tumor suppressor gene (Bajenaru et al., 2001) , we explored the possibility that mice doubly heterozygous for Tsc2 and p53 would also exhibit cooperativity to increase astrocyte numbers in vivo. Whereas both Tsc2+/7 and p53+/7 mice demonstrate a 50% increase in the number of GFAP-immunoreactive astrocytes in the CA1 region of the hippocampus, no further increases were observed in the Tsc2+/7;p53+/7 mice ( Figure  4b ). These results suggest that combined Tsc2 and p53 heterozygosity does not confer an additional growth advantage for astrocytes. Tsc2+/7 astrocytes lack a cell autonomous growth advantage in vitro To determine whether the growth advantage of Tsc2+/7 astrocytes observed in vivo represented a cell autonomous growth eect, primary astrocyte cultures were established from individual pups in three separate litters. In contrast to Nf1+/7 and p53+/7 astrocytes, Tsc2+/7 astrocyte cultures did not exhibit increased cell proliferation as measured by direct cell counting in vitro (Figure 5a ). The Tsc2+/7 astrocytes were morphologically indistinguishable from wild type cultured astrocytes and did not demonstrate any features of reactive glia (data not shown). Since primary astrocyte cultures were found to be dependent on exogenously supplied growth factors and could not survive in serum-free medium (data not shown), we examined the proliferation of Tsc2+/7 astrocytes in de®ned medium containing mouse epidermal growth factor (EGF). Under these conditions, we observed no dierence in cell proliferation between Tsc2+/7 and wild type astrocytes. Both Tsc+/7 and wild type astrocytes died with similar kinetics in the absence of serum or EGF. This absence of a growth advantage during log phase growth was also observed in Tsc27/7 mouse embryonic ®broblasts (data not shown). However, complete loss of tuberin expression in the Tsc27/7 MEFs was associated with continued growth after con¯uence (Figure 6a ; denoted by the arrow). Previous experiments in our laboratory demonstrated that contact inhibition is a potent growth arrest signal for astrocytes in vitro (Gutmann et al., 1999; Hewett et al., 1995) . To examine con¯uence-associated growth arrest, astrocytes were allowed to reach con¯uency and the number of viable astrocytes were counted 48 ± 72 h later. No dierences in saturation density between Tsc2+/7 and wild type astrocytes were detected ( Figure 5b ). In contrast, absent tuberin expression in Tsc27/7 MEFs was associated with a statistically signi®cant increase in saturation density (Figure 6b ). Moreover, saturation density returned to levels seen with Tsc2+/+ MEFs upon expression of a human wild type TSC2 cDNA ( Figure 6b ). Lastly, neither Tsc2+/7 astrocytes nor Tsc27/7 mouse embryonic ®broblasts demonstrated anchorage-independent growth (data not shown). These data suggest that the growth advantage seen in Tsc2+/7 astrocytes in vivo does not re¯ect a cell autonomous growth advantage in vitro and that total loss of tuberin expression, as opposed to reduced tuberin expression, may be required to impair cell contact-dependent growth arrest in vitro.
Heterozygosity for Tsc2 results in reduced p27-Kip1 expression in vitro
To explore the possibility that reduced tuberin expression results in other cellular eects previously ascribed to tuberin de®ciency, we examined Tsc2+/7 astrocytes for abnormalities in¯uid phase endocytosis and p27-Kip1 expression. We did not ®nd any dierences in¯uid-phase endocytosis as measured by horseradish peroxidase (HRP) uptake in Tsc2+/7 Figure 3 Western analysis of whole brain lysates from wild type and Tsc2+/7 mice. Reduced expression of tuberin (top panel) is not associated with increased expression of glial ®brillary acidic protein (GFAP, second panel), vimentin (third panel), or Apolipoprotein E (ApoE, fourth panel) in Tsc2+/7 brains. SDS ± PAGE analysis of whole brain lysates of Tsc2+/7 and wild type mice was performed with 20 mg total protein, as determined by the BCA method. The bottom panel shows a tubulin control to demonstrate equal loading Figure 4 Tsc2 heterozygosity cooperates with Tsc1, but not with p53 heterozygosity in vivo. (a) GFAP-positive astrocyte counts from sections of the hippocampus CA1 region from wild type, Tsc1+/7, Tsc2+/7 and Tsc1+/7;Tsc2+/7 mice. Each bar represents the average number of astrocytes from six consecutive sections of each brain. At least four animals were analysed per genotype. A single asterisk denotes a statistically signi®cant dierence (P50.001) compared to wild type while the double asterisk denotes a statistically signi®cant (P50.01) dierence compared to both wild type and single heterozygotes. (b) GFAPpositive astrocyte counts from sections of the hippocampus CA1 region from wild type, Tsc2+/7, p53+/7, and Tsc2+/7; p53+/7 mice. Each number represents the average number of astrocytes from six consecutive sections of each brain. At least four animals were analysed per genotype. Asterisks denote a statistically signi®cant dierence compared to wild type. There is no statistically signi®cant dierence between the Tsc2+/7 and Tsc2+/7;p53+/7 mice. The numbers below the genotype of each strain represent the fold-increase of astrocyte number over wild type Oncogene Tsc heterozygosity in astrocytes EJ Uhlmann et al astrocytes compared to astrocytes derived from wild type littermates (Figure 5c ). These results suggested one of two possibilities; either reduced tuberin expression was not sucient to cause any change in uid phase endocytosis or tuberin does not directly regulate this process. To determine whether complete loss of tuberin is associated with increased HRP uptake, we examined Tsc27/7 mouse embryonic ®broblasts (MEFs). In these experiments, we consistently observed an increase in HRP uptake in tuberin de®cient MEFs compared to Tsc2+/+ cells. One representative pair of Tsc2+/+ and Tsc27/7 MEFs is shown in Figure 6c . To determine whether the increased encodytosis previously reported by others in Tsc27/7 ®broblasts was directly due to tuberin absence, we generated several Tsc27/7 MEF clones that re-expressed full-length tuberin ( Figure 7b ). As shown in Figure 6c , expression of wild type tuberin in these same clones had no eect HRP uptake, while it was capable of restoring normal growth regulation (Figure 6b ). Identical results were observed with an additional tuberin-replacement MEF clone (data not shown). These results suggest that tuberin does not directly regulate endocytosis.
To determine if reduced tuberin expression in Tsc2+/7 astrocytes aected p27-Kip1 stability, we analysed p27-Kip1 levels in Tsc2+/7 and matched wild type control astrocytes by Western blotting. In one representative experiment shown in Figure 7a , we observed a 60% reduction of p27-Kip1 expression in Tsc2+/7 compared to wild type astrocytes. To prove that tuberin expression directly aects p27-Kip1 protein levels, we analysed p27-Kip1 expression in tuberin-de®cient MEFs. In these experiments, Tsc27/7 MEFs lacked tuberin expression and demonstrated a 490% reduction in p27-Kip1 compared to Tsc2+/+ MEFs as determined by Western blot (Figure 7b, left panel) . Upon the re-introduction of wild type tuberin into Tsc27/7 MEFs, we observed a dramatic increase in p27-Kip1 expression in both independently generated lines, suggesting that tuberin regulates p27-Kip1 levels (Figure 7b , right panel). Collectively, these results argue that tuberin may play an important role in growth regulation by modulating p27-Kip1 expression.
Discussion
Neurological complications are the most disabling features of TSC and include epilepsy in 70 ± 80% of TSC patients, as well as autism and mental retardation in half of TSC patients. These neuropsychiatric abnormalities in TSC likely result from the eects of cortical tubers, the characteristic brain lesions of TSC, on brain function (Crino and Henske, 1999) . Tubers are developmental abnormalities of cerebral cortical cytoarchitecture (a form of cortical dysplasia) characterized histologically by disorganized cortical lamination and cells with aberrant morphologies, including increased numbers of astrocytes. Past and recent mutational analysis studies have demonstrated that TSC gene mutations and LOH are not observed (or rarely seen) in the CNS lesions in TSC (Henske et al., Cultured Tsc2+/7 astrocytes demonstrated no dierence in saturation density compared to control Tsc2+/+ astrocytes. Equal number of astrocytes in con¯uent cultures for each genotype were established in 35 mm dishes in triplicate. Cells were cultured in DMEM supplemented with 10% FCS in the presence of 10 ng/ml of mouse EGF and live cells were counted 3 days after reaching con¯uence. (c) Fluid-phase endocytosis of cultured Tsc2+/7 astrocytes demonstrated no dierence in the rate of endocytosis compared to control Tsc2+/+ astrocytes. Derivative astrocytes were seeded at passage 2 in 6-well plates and the rate of¯uid-phase endocytosis determined as described in the Materials and methods section 1996; Wolf et al., 1997; Niida et al., 2001; Parry et al., 2000) , suggesting that TSC gene heterozygosity, resulting in reduced hamartin or tuberin expression, might be sucient for the development of these abnormalities.
Since heterozygosity for the TSC gene products may account for some of the abnormalities in TSC patient brains, we sought to determine the eects of reduced Tsc gene expression on astrocyte growth. In this report, Figure 7 Tsc2+/7 astrocytes as well as Tsc27/7 mouse embryonic ®broblasts exhibit decreased levels of p27-Kip1. (a) Tsc2+/7 astrocytes display decreased p27-Kip1 expression and reduced tuberin expression compared to wild type controls in vitro. Con¯uent cultures of astrocytes were lysed and 20 mg total protein was loaded in each lane. Blotting for tubulin was performed to demonstrate equal loading. (b) Representative wild type (#5) and Tsc2 null (#2) mouse embryonic ®broblast lines or Tsc27/7 clones (#2) re-expressing tuberin (clones Tsc2-2 and Tsc2-5) were analysed for p27-Kip1 expression. Western analysis of tuberin expression (middle panel) was performed to demonstrate tuberin replacement. Whereas the Tsc27/7 MEFs had dramatically reduced p27-Kip1 expression relative to Tsc2+/+ MEFs, the introduction of wild type tuberin resulted in the restoration of p27-Kip1 expression in the two independently derived Tsc27/7 MEF lines. The bottom panel includes tubulin as a control for equal loading Figure 6 Tsc27/7 mouse embryonic ®broblasts demonstrate enhanced in vitro growth and altered¯uid-phase endocytosis. (a) Rates of logarithmic growth are identical in wild type and Tsc27/7 mouse embryonic ®broblasts (data not shown). To analyse saturation density growth, 4610 4 cells were plated in 35 mm dishes and cultured in DMEM supplemented with 10% FCS. Cells were trypsinized, stained with 0.2% Trypan blue and live cells were counted in triplicates for each time point. Cultures reached con¯uency on day 3 (arrow), therefore this data represents the behavior of cells at high saturation density. (b) Cultured Tsc27/7 mouse embryonic ®broblasts demonstrated higher saturation density compared to control Tsc2+/+ mouse embryonic ®broblasts. Saturation density was reduced to control level upon re-expression of wild type human tuberin in Tsc27/7 mouse embryonic ®broblasts. Equal number of cells in con¯uent cultures for each genotype were established in 35 mm dishes in triplicate. Cells were cultured in DMEM supplemented with 10% FCS and live cells were counted on day 3. Asterisks denote a statistically signi®cant dierence when compared to wild-type MEFs. (c) Tsc27/7 MEFs demonstrated increased HRP uptake compared to Tsc2+/+ controls and the rate of¯uid-phase endocytosis was unchanged upon the re-expression of tuberin. Six wells per MEF line were seeded in 6-well plates and endocytosis performed as described in the Materials and methods section. The asterisk denotes a statistically signi®cant dierence compared to wild type. These experiments were performed on at least two cell lines per genotype Oncogene Tsc heterozygosity in astrocytes EJ Uhlmann et al we demonstrate that both Tsc1 and Tsc2 heterozygous mice exhibit a 50% increase in astrocyte number in vivo. We did not observe gross or microscopic evidence for morphological brain abnormalities in the Tsc1+/7 or Tsc2+/7 mice. No lesions suggestive of cortical tubers or focal dysplasias were noted. Moreover, no dierences in hippocampal cross-sectional areas were seen to account for the increases in astrocyte number. Although a detailed analysis of other brain regions was not performed, the increase in astrocyte number was uniformly distributed throughout the brain and was not restricted to the hippocampus. These results suggest that Tsc gene heterozygosity, such as that observed in patients with TSC, might result in abnormalities in astrocyte number, but is not sucient to account for the characteristic histopathological lesions, such as tubers and cortical dysplasias.
Since we used GFAP as a marker for astrocytes and GFAP upregulation has been associated with astrogliosis, we performed additional analyses to determine whether the increase in GFAP-immunoreactive cells in the Tsc2 heterozygote brains re¯ected reactive astrogliosis. In Tsc2+/7 brains, we did not observe increased expression of three proteins whose increased expression has been associated with reactive astrogliosis (GFAP, ApoE, and vimentin). These results argue that the increase in GFAP-immunoreactive cells more likely re¯ects an increase in cell number and not reactive astrogliosis. While we might have expected an increase in total GFAP expression in Tsc2+/7 brains if each individual astrocyte expressed the same amount of GFAP per cell, we appreciate that immunohistochemistry is not quantitative and only provides information on the number of cells that express GFAP at levels to be detectable by this method.
To explore the possibility that Tsc2 heterozygosity might confer an additional growth advantage for astrocytes if coupled with alterations in other astrocyte growth regulators, we generated mice doubly heterozygous for Tsc2 and Tsc1 as well as Tsc2 and p53. In these experiments, we observed a cooperative astrocyte growth advantage in mice doubly heterozygous for a targeted mutation in both Tsc1 and Tsc2. As tuberin and hamartin have been shown to interact in a variety of cell types (van Slegtenhorst et al., 1998; Plank et al., 1998; Nellist et al., 1999) , including astrocytes (Gutmann et al., 2000) , it is possible that the combined reduction of tuberin and hamartin signi®cantly reduces the amount of the functional tuberin-hamartin complex required for growth regulation and thus further promotes astrocyte proliferation. In support of this hypothesis, preliminary data suggest that the compound Tsc1;Tsc2 heterozygotes develop tumors at an accelerated pace than either heterozygous animal alone (Onda and Kwiatkowski, manuscript in preparation) . Experiments are in progress to determine the consequence of Tsc1 and Tsc2 heterozygosity on the stability of the tuberin-hamartin complex.
In contrast to the cooperativity observed between Tsc1 and Tsc2 heterozygosity, we observed no such genetic cooperativity between Tsc2 and p53 heterozygosity. Previous experiments on mice heterozygous for a targeted defect in the neuro®bromatosis 1 (Nf1) gene have demonstrated signi®cant genetic cooperativity between Nf1 and p53 (Bajenaru et al., 2001) . This genetic cooperativity between Nf1+/7;p53+/7 mice was also re¯ected in malignant tumor formation (Reilly et al., 2000) . Unlike the situation with Nf1, Tsc2;p53 double heterozygosity does not confer an additional astrocyte growth advantage compared to Tsc2 heterozygosity alone. In one TSC-associated tumor, no abnormal p53 immunoreactivity, suggestive of a p53 mutation, was observed (Lantuejoul et al., 1997) . Further work will be required to determine whether this lack of cooperativity re¯ects a p53-independent mechanism of action for tuberin.
To determine whether the increased astrocyte number observed in vivo re¯ected a cell autonomous growth advantage, primary astrocyte cultures from Tsc2+/7 mice were derived and compared with wild type astrocytes. In contrast with our previous experiments on Nf1+/7 astrocytes (Bajenaru et al., 2001) , we observed no dierences in Tsc2+/7 astrocyte growth in vitro. It is possible that our experiments did not provide the correct cellular context in which to maximize the potential dierences in astrocyte growth between Tsc2+/7 and wild type astrocytes. We do not favor this possibility for two reasons. First, we examined Tsc2+/7 astrocyte cell growth under a variety of conditions and could not demonstrate any growth dierences. Second, our Tsc27/7 MEF data and other recent results from our laboratory using Tsc17/7 astrocytes demonstrate no dierences in logphase doubling times compared to wild type cells under identical growth conditions (Uhlmann and Gutmann, manuscript in preparation). Based on these observations, we suggest that the astrocyte growth advantage observed in vivo re¯ects a context-dependent growth increase imparted by the brain microenvironment. Experiments are planned to determine whether Tsc2+/7 astrocytes will demonstrate a growth advantage when explanted into Tsc2+/7 versus wild type brains in vivo.
Previous studies have implicated tuberin in endocytosis (through Rab5b GAP activity), modulating rap1 activity, and stabilizing p27-Kip1. Our data do not demonstrate any direct eect of reduced tuberin expression or replacement in Tsc2 de®cient MEFs on endocytosis activity or rap1 regulation (G Boss, unpublished results). These observations suggest that tuberin action is unlikely to be related to modulation of endocytosis or rap1 signaling.
In contrast, Tsc2+/7 astrocytes and Tsc27/7 MEFs exhibit reduced expression of the cell cycle control protein, p27-Kip1. Furthermore, this p27-Kip1 reduction was rescued by re-expressing the human TSC2 gene in the Tsc2-null MEFs. The fact that heterozygote Tsc2 astrocytes also demonstrate reduced p27-Kip1 expression strengthens the argument that p27-Kip1 might be an important eector of tuberin growth suppression. p27-Kip1 is a cell cycle inhibitory protein that exerts its in¯uence at the G1/S checkpoint and functions by binding with the cyclin E-cdk2 complex to prevent its activation. Mice lacking p27-Kip1 demonstrate increased cell growth as measured by animal, organ, and cellular sizes. An intermediate cell growth eect is also observed in p27+/7 mice (Fero et al., 1996) . Importantly, p27-Kip1 expression is upregulated in response to cell-cell contact, suggesting a role in contact inhibition growth arrest (Hengst et al., 1994) . The data presented in this report demonstrating that tuberin-de®cient MEFs exhibit a higher saturation density compared to wild type cells and that this dierence was abrogated by re-expression of human tuberin argues that the growth regulatory eects of tuberin may operate during contact inhibition. Recent observations from our laboratory on Tsc17/7 astrocytes similarly demonstrate abnormalities in saturation density (Uhlmann and Gutmann, unpublished results) . The fact that we did not observe this saturation density eect in Tsc2+/7 astrocytes suggests that this abnormal growth regulation might require either the appropriate brain context or the complete absence of tuberin expression. Studies are presently underway to determine the requirement for p27-Kip1 in Tsc gene product-mediated astrocyte growth arrest in vitro and in vivo.
The results presented in this report support the notion that Tsc heterozygosity is sucient to confer a growth advantage for astrocytes in vivo, but is not sucient to provide a cell autonomous increase in cell proliferation in vitro. The connection between p27-Kip1 expression, Tsc2 gene function, and growth regulation raises the possibility that astrocyte dysfunction in the correct cellular context in the developing brain may result in some of the nervous system abnormalities in TSC. Further experiments on Tsc heterozygosity in the brain will be required to fully address these possibilities.
Materials and methods

Antibodies and plasmids
Anti-hamartin antibodies were generated by cloning the BglII-HpaI fragment of the human hamartin cDNA into pQE32. The 6xHis-tagged C-terminal 204 amino acid fragment of hamartin was expressed in bacteria and rabbit polyclonal antibody (HM-4) was raised according to standard protocols. Other antibodies were purchased from commercial sources as follows: tuberin; sc-893 (Santa Cruz), p27-Kip1; sc-528 (Santa Cruz), tubulin; DM1A (Sigma), GFAP; 13-0300 (Zymed), ApoE; 178479 (Calbiochem), and vimentin; LN6 (Sigma). The pcDNA6-hTsc2 mammalian expression vector containing the full-length human tuberin cDNA was generated by cloning fragments of the full length human TSC2 gene obtained from European consortium or isolated from a human fetal brain cDNA library (Stratagene) into pcDNA6/V5-HisA (H Onda & D Kwiatkowski, unpublished data) . The sequence is identical to nucleotides 14-5470 of the published sequence (The European Chromosome 16 Tuberous Sclerosis Consortium, 1993) containing a Kozak consensus sequence, an initiation codon, and the endogenous termination codon at nucleotide 5468.
Mice
Tsc2+/7 mice were generated as described previously (Onda et al., 1999) . The colony was maintained at the animal facility of our institution by breeding heterozygous pairs. Ospring were genotyped by simultaneous PCR ampli®cation of the disrupted wild type and Tsc2 alleles using the primers H162, H163 and H164 from tail DNA (Onda et al., 1999) . Tsc1;Tsc2 double heterozygotes were generated by intercrossing at the Brigham and Women's Hospital Animal Facility. Tsc1+/7 mice were generated by homologous recombination in ES cells (complete description to be published elsewhere; H Onda & D Kwiatkowski, unpublished observations) . p53+/7 mice were obtained from Dr Tyler Jacks (Donehower et al., 1992; Jacks et al., 1994) . The double heterozygous mice were generated in our Animal Facility by intercrossing Tsc2+/7 with p53+/7 mice. All strains are maintained as permanent colonies at the Washington University School of Medicine. All animal procedures were carried out following our institution's Animal Studies Committee Manual using protocols approved by the Animal Studies Committee of Washington University. All experiments were performed on paired littermates.
Primary astrocyte cultures and analysis of growth
Neocortical astrocyte cultures were established from postnatal day 2 mice as previously described (Hewett et al., 1995) . Astrocyte purity was assessed by GFAP immunocytochemistry (497% GFAP-immunoreactive cells). Genotypes were determined at that time as described above. Astrocytes were initially seeded as separate cultures (passage 0) and equal numbers of¯asks are pooled for each genotype (passage 1). Experiments were performed at passage 2. Astrocyte proliferation in culture was determined by direct counting. 4610 4 cells were seeded in 35 mm dishes and incubated in DMEM supplemented with 10% FCS, 10 ng/ml mouse EGF (E-4127, Sigma), 50 mg/ml penicillin and 50 mg/ml streptomycin. Cells were trypsinized and the number of Trypan blue-excluding cells was determined by direct counting on a hemacytometer in triplicate on days 1 ± 6. Anchorageindependent growth was assessed by growth in soft agar using protocols established in our laboratory . Brie¯y, 2500 astrocytes were plated in 24-well plates with medium containing 0.3% Noble agar for 14 ± 21 days. The number of colonies was determined by direct counting on an inverted microscope and the mean and standard deviation determined for each condition. Each experiment was repeated three times with similar results. Anchorage-independent growth was measured by seeding 2.5610 3 cells in 0.3% Noble agar in quadruplicate wells of a 24-well plate. The number of colonies was determined by direct counting after 2 ± 3 weeks. C6 rat glioma cells were used as a positive control.
Immunostaining and astrocyte counting
Five to six-week-old mice were anesthetized with pentobarbital and perfused transcardially with 0.1 M Na-phosphate buer, pH 7.4, followed by 4% paraformaldehyde in 0.1 M Na-phosphate buer. The brains were removed and further ®xed in 4% paraformaldehyde in 0.1 M Na-phosphate buer for 24 h at 48C. After cryopreservation in 30% sucrose, the brains were frozen in dry ice and sectioned in the coronal plane on a MICROME HM 400 microtome. Astrocytes were identi®ed in 40 mm free-¯oating sections by glial ®brillary acidic protein (GFAP) immunostaining. The brain sections were incubated with a rat anti-GFAP monoclonal antibody (1 : 10 000 dilution) and a biotinylated secondary antibody (1 : 2000 dilution). GFAP positive cells were detected using Vectastain avidin-biotin-peroxidase kit with Vector SG substrate (Vector Laboratories). Sections were mounted on gelatin-coated slides and astrocytes were counted in a wellde®ned region (hippocampus CA1) by light microscopy. Astrocytes were counted only if all of their radial GFAPcontaining processes were in the plane of section. Six consecutive sections of each brain from at least four animals were analysed per genotype. The CA1 cross-sectional area counted was nearly identical in all sections from mice with dierent genotypes (0.348+0.023 mm 2 ).
Endocytosis assay
Fluid-phase endocytosis was assayed as described previously (Stenmark et al., 1995) with minor modi®cations. Astrocytes or mouse embryonic ®broblasts were seeded in 6-well plates and incubated in DMEM supplemented with 10% FCS. For astrocytes, 10 ng/ml mouse EGF was included in the media. Twenty-four hours later, cells were washed three times with DMEM and 1% horseradish peroxidase (P-8250, Sigma) in DMEM was added for 1 h. Cells were washed with PBS ®ve times and lysed in 100 ml/well of 10 mM HEPES pH 7.2, 0.2% Triton X-100 for 10 min on ice. Lysates were centrifuged at 10 000 g for 10 min and 2 ml aliquots were assayed for HRP activity in 1 ml of 0.01% o-dianiside (Sigma), 50 mM sodium phosphate pH 7.3, 0.1% Triton X-100 and 0.003% H 2 O 2 for 1 h. Total protein was determined by the BCA method (Pierce Chemical Co). Absorbance at 455 nm was adjusted for the amount of protein in all six parallels for each genotype. Each experiment was performed at least three times with similar results.
Western blot analysis
Brain or cultured astrocytes were homogenized in lysis buer (20 mM Tris pH 7.5, 10 mM EGTA, 1% NP-40, 2.5 mM Napyrophosphate, 40 mM b-glycerol phosphate, 2 mM NaVO 4 , 10 mg/ml leupeptin, 10 mg/ml benzamidine, 2 mg/ml aprotinin and 1 mM PMSF. Total protein was determined by the BCA method (Pierce Chemical Co). Twenty mg total protein for each sample was separated by SDS ± PAGE and transferred to Immobilon membranes (Millipore). Membranes were treated with blocking buer (5% nonfat dry milk in PBS-T for 1 h at room temperature, followed by incubation with the primary antibody at a dilution of 1 : 200 (vimentin), 1 : 1000 (tuberin, hamartin, p27, GFAP), 1 : 5000 (ApoE) or 1 : 10 000 (tubulin, actin) in blocking buer overnight at 48C. After three washes in PBS-T, the membranes were incubated with the secondary antibody at a dilution of 1 : 3000 at room temperature for 1 h. Detection was performed using enhanced chemiluminescence (Amersham Life Science).
Cell lines and analysis of growth
Mouse embryonic ®broblast lines from Tsc27/7;p537/7 and Tsc2+/+;p537/7 animals will be described in detail elsewhere (H Onda and D Kwiatkowski, unpublished results). Cells were grown in DMEM supplemented with 10% FCS, 50 mg/ml penicillin and 50 mg/ml streptomycin. Line 112 (Tsc27/7;p537/7) was transfected with 8 mg pcDNA6-hTsc2 plus 2 mg SV40-puro in T25¯asks using the calciumphosphate method. Selection was performed by the addition of 2 mg/ml puromycin (P-7255, Sigma) to the growth media. Individual clones were isolated, expanded and tested for tuberin expression by Western blotting. Experiments were performed at early passages (12 ± 20). For counting, 4610 4 cells were seeded in 35-mm dishes and incubated overnight in DMEM supplemented with 10% FCS and 2 mg/ ml puromycin. The media was changed in every 2 days. Cells were trypsinized and Trypan blue excluding cells were counted in triplicate on days 1 ± 6. Each experiment was performed at least three times with similar results.
Statistical analysis
Data in each experiment are presented as mean+s.d. and were analysed with ANOVA followed by the Bonferoni t-test at the P50.05 level.
